0001562180-20-005231.txt : 20200730 0001562180-20-005231.hdr.sgml : 20200730 20200730182253 ACCESSION NUMBER: 0001562180-20-005231 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200728 FILED AS OF DATE: 20200730 DATE AS OF CHANGE: 20200730 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MONTECALVO DAVID A CENTRAL INDEX KEY: 0001241973 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-08036 FILM NUMBER: 201060899 MAIL ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC CENTRAL INDEX KEY: 0000105770 STANDARD INDUSTRIAL CLASSIFICATION: FABRICATED RUBBER PRODUCTS, NEC [3060] IRS NUMBER: 231210010 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 6105942900 MAIL ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: WEST CO INC DATE OF NAME CHANGE: 19990405 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2020-07-28 false 0000105770 WEST PHARMACEUTICAL SERVICES INC WST 0001241973 MONTECALVO DAVID A 530 HERMAN O. WEST DRIVE EXTON PA 19341 false true false false SVP, Glob Ops and Supply Chain Common Stock 2020-07-28 4 M false 10792.00 71.79 A 15732.42 D Common Stock 2020-07-28 4 M false 3000.00 83.47 A 18732.42 D Common Stock 2020-07-28 4 S false 716.00 266.058 D 18016.42 D Common Stock 2020-07-28 4 S false 7773.00 264.1315 D 10243.42 D Common Stock 2020-07-28 4 S false 2881.00 265.1292 D 7362.42 D Common Stock 2020-07-28 4 S false 138.00 265.8507 D 7224.42 D Common Stock 2020-07-28 4 S false 3000.00 265.9769 D 4224.42 D Common Stock 2020-07-29 4 M false 5358.00 83.47 A 9582.42 D Common Stock 2020-07-29 4 S false 3273.00 270.7038 D 6309.42 D Stock Option (Right to Buy) 71.79 2020-07-28 4 M false 10792.00 0.00 D 2017-02-23 2026-09-26 Common Stock 10792.00 0.00 D Stock Options (Right to buy) 83.47 2020-07-28 4 M false 3000.00 0.00 D 2018-02-21 2027-02-21 Common Stock 3000.00 8144.00 D Stock Options (Right to buy) 83.47 2020-07-29 4 M false 5358.00 0.00 D 2018-02-21 2027-02-21 Common Stock 5358.00 2786.00 D The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $263.80 to $264.79, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $264.80 to $265.77, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $265.80 to $265.87, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $265.9762 to $265.9769, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. Ryan Metz as Agent for David A. Montecalvo 2020-07-29